Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2025-12-26 @ 2:58 AM
Study NCT ID:
NCT00332202
Status:
COMPLETED
Last Update Posted:
2018-09-10
First Post:
2006-05-30
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-06
Start Date Type:
None
Primary Completion Date:
2013-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-07
Completion Date Type:
ACTUAL
First Submit Date:
2006-05-30
First Submit QC Date:
None
Study First Post Date:
2006-06-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-05-30
Results First Submit QC Date:
None
Results First Post Date:
2018-09-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2013-05-08
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-09-06
Last Update Post Date:
2018-09-10
Last Update Post Date Type:
ACTUAL